Mortality Signal Emerges 2 Years After Valve-in-Valve TAVR for Failed SAVR
Alternative to redo surgery associated with several-fold increase in deaths, HF hospitalization
Stay updated with breaking news from Robert Bonow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alternative to redo surgery associated with several-fold increase in deaths, HF hospitalization
On the other hand, conventional assays did predict a complicated course in acute PE
With only 2-year follow-up it’s challenging to interpret long-term outcomes, says Yousif Ahmad.
If the device is approved, “I am very excited to put this to use because we have an unmet need,” Pinak Shah says.
The Trilogy transcatheter aortic valve replacement system was safe and effective for high-risk surgical patients with aortic regurgitation, improving LV remodeling and function, in the ALIGN-AR trial.